Skip to content

TRANSFORMING

the treatment of stroke

Graphic of brain neurons
NeuroTrauma Sciences (NTS), founded in 2016, is a clinical stage biopharmaceutical company focused on improving the lives of stroke patients. NTS’ lead indications are acute ischemic stroke (AIS) and chronic stroke. We are completing Phase 1 with our lead compound, NTS-104, in 2025.

Learn More

OUR TEAM

Led by industry and medical neuroscience experts.

Photo of monitors with brain scans

Top